Stay updated on CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page’s UI revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a system/interface update rather than a change to the study record contents.
    Difference
    0.1%
    Check dated 2026-04-24T22:17:26.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:45:45.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 to the history and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T20:46:31.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Record history shows the addition of revision v3.4.3 and the removal of revision v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T19:44:44.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.4.2 instead of v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-12T00:01:35.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Only a backend revision update is visible, changing from v3.4.0 to v3.4.1; no study records, content, or navigation were altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:40:00.000Z thumbnail image

Stay in the know with updates to CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page.